Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Biol Pharm Bull ; 43(2): 319-324, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32009118

RESUMO

We examined the influence of liver disease on the absorption from the liver surface of fluorescein isothiocyanate (FITC)-dextran 10 (FD-10, MW: 11000) and several marker compounds with different molecular weights. The purpose of this study was to determine the feasibility of liver surface application of macromolecular compounds in the disease state. We used male Wistar rats treated with carbon tetrachloride (CCl4) or D-galactosamine (GAL). FD-10 and other marker compounds were applied to the liver surface using a cylindrical diffusion cell in liver-intoxicated rats. The blood, bile, urine, and the remaining solution in the diffusion cell were collected for assay. FD-10 was absorbed by first-order kinetics from the liver surface in the liver-intoxicated rat models. The calculated rate constant ka values in the normal, CCl4 and GAL groups were 0.000965, 0.00125 and 0.00104 min-1, respectively. Increased absorption of FITC-dextrans in the liver-intoxicated rats was observed. In both CCl4 and GAL groups, an inverse relationship was observed between the molecular weight and ka from the rat liver surface of the marker compounds. The limits of the molecular weight absorbed from the liver surface were extrapolated to be 71200, 135000, and 105000 in the normal, CCl4, and GAL groups, respectively. In conclusion, increased absorbability from the rat liver surface indicates that liver surface application for liver targeting of macromolecules in the diseased state is indeed feasible. Therefore, our findings can support further research on liver surface application of drugs under liver disease.


Assuntos
Tetracloreto de Carbono/toxicidade , Dextranos/metabolismo , Fluoresceína-5-Isotiocianato/análogos & derivados , Galactosamina/toxicidade , Fígado/efeitos dos fármacos , Fígado/metabolismo , Animais , Dextranos/sangue , Fluoresceína-5-Isotiocianato/metabolismo , Masculino , Ratos , Ratos Wistar
2.
Biol Pharm Bull ; 43(9): 1324-1330, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32879206

RESUMO

The pharmacokinetics of some hepatically cleared drugs have been reported to fluctuate in patients with renal impairment, but the definitive factors have not been clarified. We compared the pharmacokinetics of some drugs with different hepatic elimination processes in a chronic kidney disease (CKD) rat model, to optimize their administration during kidney injury. We chose indocyanine green (ICG), midazolam (MDZ), and acetaminophen (APAP) as reference drugs to determine changes in hepatic clearance pathways in presence of CKD. Drugs were intravenously administered via the jugular vein to the CKD model rats, previously established by adenine administration, and then, blood, bile, and urine samples were collected. The plasma concentration of ICG, which is eliminated into the bile without biotransformation, increased; and its total body clearance (CLtot) significantly decreased in the CKD group compared to the control group. Moreover, the plasma concentrations of MDZ and APAP, metabolized in the liver by CYP3A and Ugt1a6 enzymes, respectively, were higher in the CKD group than in the control group. The biliary clearances of APAP and its derivative APAP-glucuronide increased in the CKD group, whereas their renal clearances were markedly decreased with respect to those in the control group. Altogether, plasma concentrations of some hepatically eliminated drugs increased in the CKD rat model, but depending on their pharmacokinetic characteristics. This study provides useful information for optimizing the administration of some hepatically cleared drugs in CKD patients.


Assuntos
Eliminação Hepatobiliar/fisiologia , Fígado/fisiopatologia , Insuficiência Renal Crônica/fisiopatologia , Acetaminofen/administração & dosagem , Acetaminofen/análogos & derivados , Acetaminofen/farmacocinética , Adenina/administração & dosagem , Adenina/toxicidade , Administração Intravenosa , Animais , Citocromo P-450 CYP3A/metabolismo , Modelos Animais de Doenças , Glucuronosiltransferase/metabolismo , Humanos , Verde de Indocianina/administração & dosagem , Verde de Indocianina/farmacocinética , Rim/efeitos dos fármacos , Rim/fisiopatologia , Testes de Função Renal , Fígado/metabolismo , Masculino , Taxa de Depuração Metabólica/fisiologia , Midazolam/administração & dosagem , Midazolam/farmacocinética , Ratos , Ratos Wistar , Eliminação Renal , Insuficiência Renal Crônica/sangue , Insuficiência Renal Crônica/induzido quimicamente
3.
Xenobiotica ; 50(6): 654-662, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31631733

RESUMO

1. The expression and activity of drug-metabolizing enzymes are known to affect the pharmacokinetics of drugs metabolized in the liver. Here, we assessed the effect of acetaminophen (APAP)-induced hepatotoxicity on the mRNA expression of drug-metabolizing enzymes and elucidated the underlying mechanism using three-dimensional (3D) cultures of HepG2 cells.2. 3D culture cells enabled us to establish an in vitro model of APAP-induced hepatotoxicity which showed the increase in N-acetyl-p-benzoquinone imine production, reactive oxygen species (ROS) generation and cellular injury.3. In this 3D culture model, APAP treatment significantly increased the mRNA expression of drug-metabolizing enzymes (cytochrome P450 [CYP]3A4, CYP2E1 and UDP-glucuronosyltransferase 1A6) and their nuclear receptors (pregnane X receptor and constitutive androstane receptor) compared with untreated cells. Treatment with N-acetylcysteine, a therapeutic agent for APAP-induced hepatotoxicity, suppressed these increases. In addition, the mRNA expression of drug-metabolizing enzymes and nuclear receptors were elevated depending on the concentration of H2O2, one of ROS involved in the development of APAP-induced hepatotoxicity. The mRNA expression of nuclear receptors increased before that of drug-metabolizing enzymes.4. In conclusion, ROS may induce the mRNA expression of nuclear receptors and promote the transcription of drug-metabolizing enzymes in the in vitro model of APAP-induced hepatotoxicity.


Assuntos
Acetaminofen/metabolismo , Doença Hepática Induzida por Substâncias e Drogas/metabolismo , RNA Mensageiro/metabolismo , Acetaminofen/toxicidade , Doença Hepática Induzida por Substâncias e Drogas/genética , Receptor Constitutivo de Androstano , Citocromo P-450 CYP2E1/metabolismo , Células Hep G2 , Hepatócitos/metabolismo , Humanos , Inativação Metabólica , Fígado , Taxa de Depuração Metabólica , Receptores Citoplasmáticos e Nucleares
4.
J Am Chem Soc ; 141(44): 17744-17753, 2019 11 06.
Artigo em Inglês | MEDLINE | ID: mdl-31607118

RESUMO

Red or near-infrared (NIR) light responsive molecules have received much attention for biological and material applications because potentially harmful UV light for materials and cells is not required for the photochemical reactions. Although some molecular designs for photochromic molecules to increase the photosensitivity to red or NIR light have been reported, the strategies are limited to the extension of π-conjugation length and the utilization of charge transfer transition or energy and electron transfers. Triplet fusion is an attractive tool to cause chemical reactions by converting low-energy excitation light to high-energy upconversion light. However, the efficient use of the high energy of upconversion light is difficult because almost all reported triplet fusion systems rely on reabsorption of upconversion light. Here, we demonstrated red-light-driven photochromism via the triplet fusion of a phenoxyl-imidazolyl radical complex, Pery-RPIC, that has a covalently bonded perylene as an annihilator unit. The femtosecond time-resolved absorption and fluorescence spectroscopy revealed that this photochromic reaction proceeds by the highly efficient singlet energy transfer from the annihilator unit to the photochromic unit. This strategy can be applied not only to the development of visible and NIR light responsive photochromic system but also to various photochemical reactions.

5.
Biopharm Drug Dispos ; 38(6): 367-372, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28239866

RESUMO

This study investigated the effect of epinephrine (a vasoconstrictor) and hydralazine (a vasodilator) on the hepatic disposition of 5-fluorouracil (5-FU) after application to the surface of the liver in rats. Normal livers were compared with a Walker 256 carcinoma cell tumor model. A cylindrical diffusion cell was attached to the liver surface. 5-Fluorouracil was added into the diffusion cell in combination with vasomodulators or after pretreatment with epinephrine. After selected treatment times, the 5-FU concentrations were assayed at three sites in the excised livers. The 5-FU concentration in the region under the cell attachment site (site 1) was significantly higher after concomitant application of 5-FU and epinephrine, compared with 5-FU alone, and increased in an epinephrine dose-dependent manner. On the other hand, preferential distribution of 5-FU at site 1 was not seen when applied in combination with hydralazine. After 10 min of epinephrine pretreatment, the concentration of 5-FU at site 1 was approximately two times higher than that for the control. Furthermore, the 5-FU concentration at site 1 of the tumor model was greatly increased compared with the normal liver. These results suggest that application of epinephrine to the liver surface might enhance the accumulation of 5-FU at the desired target site.


Assuntos
Antimetabólitos Antineoplásicos/farmacocinética , Carcinoma 256 de Walker/metabolismo , Fluoruracila/farmacocinética , Fígado/metabolismo , Vasoconstritores/farmacologia , Vasodilatadores/farmacologia , Animais , Linhagem Celular Tumoral , Epinefrina/farmacologia , Hidralazina/farmacologia , Masculino , Ratos Wistar
6.
J Gastroenterol ; 58(1): 53-68, 2023 01.
Artigo em Inglês | MEDLINE | ID: mdl-36301364

RESUMO

BACKGROUND: To establish a treatment option for liver fibrosis, the possibility of the drug repurposing theory was investigated, with a focus on the off-target effects of active pharmaceutical ingredients. METHODS: First, several active pharmaceutical ingredients were screened for their effects on the gene expression in the hepatocytes using chimeric mice with humanized hepatocytes. As per the gene expression-based screening assay for 36 medications, we assessed the mechanism of the antifibrotic effect of letrozole, a third-generation aromatase inhibitor, in mouse models of liver fibrosis induced by carbon tetrachloride (CCl4) and a methionine choline-deficient (MCD) diet. We assessed liver histology, serum biochemical markers, and fibrosis-related gene and protein expressions in the hepatocytes. RESULTS: A gene expression-based screening assay revealed that letrozole had a modifying effect on fibrosis-related gene expression in the hepatocytes, including YAP, CTGF, TGF-ß, and CYP26A1. Letrozole was administered to mouse models of CCl4- and MCD-induced liver fibrosis and it ameliorated the liver fibrosis. The mechanisms involved the inhibition of the Yap-Ctgf profibrotic pathway following a decrease in retinoic acid levels in the hepatocytes caused by suppression of the hepatic retinol dehydrogenase, Hsd17b13 and activation of the retinoic acid hydrogenase, Cyp26a1. CONCLUSIONS: Letrozole slowed the progression of liver fibrosis by inhibiting the Yap-Ctgf pathway. The mechanisms involved the modification of the Hsd17b13 and Cyp26a1 expressions led to the suppression of retinoic acid in the hepatocytes, which contributed to the activation of Yap-Ctgf pathway. Because of its off-target effect, letrozole could be repurposed for the treatment of liver fibrosis. The third-generation aromatase inhibitor letrozole ameliorated liver fibrosis by suppressing the Yap-Ctgf pathway by partially modifying the Hsd17b13 and Cyp26a1 expressions, which reduced the retinoic acid level in the hepatocytes. The gene expression analysis using chimeric mice with humanized liver revealed that the mechanisms are letrozole specific and, therefore, may be repurposed for the treatment of liver fibrosis.


Assuntos
Inibidores da Aromatase , Cirrose Hepática , Camundongos , Animais , Letrozol/efeitos adversos , Inibidores da Aromatase/efeitos adversos , Ácido Retinoico 4 Hidroxilase/metabolismo , Cirrose Hepática/patologia , Fígado/patologia , Hepatócitos/patologia , Fator de Crescimento do Tecido Conjuntivo/metabolismo , Fator de Crescimento do Tecido Conjuntivo/farmacologia , Fator de Crescimento do Tecido Conjuntivo/uso terapêutico , Preparações Farmacêuticas/metabolismo , Tretinoína/farmacologia
7.
J Trauma Acute Care Surg ; 90(2): 281-286, 2021 02 01.
Artigo em Inglês | MEDLINE | ID: mdl-33264266

RESUMO

INTRODUCTION: Repulsive guidance molecule a (RGMa) is a key protein that negatively regulates neuronal regeneration as its inhibition enhances axonal growth and promotes functional recovery in animal models of spinal cord injury. However, the role of RGMa in traumatic brain injury (TBI) remains elusive. This study aimed to clarify TBI-responsive RGMa expression in a murine model. METHODS: Adult male C57BL/6J mice were subjected to controlled cortical impact. Brains were extracted 6 hours and 1, 3, 7, 14 and 21 days after injury (n = 6 in each group). Changes in the messenger RNA (mRNA) expression of RGMa and its receptor, neogenin, were evaluated by quantitative polymerase chain reaction in the damaged area of the cortex and contralateral cortex, along with expression measurement of inflammation-related molecules. Neurological deficit was also assessed by the cylinder test. RESULTS: Neurological score was consistently lower in the TBI group compared to the sham group throughout the experimental period. The mRNA expressions of representative inflammatory cytokine TNF-α and chemokine receptor CCR2 were remarkably increased in the injured cortex on day 1 and gradually decreased over time, although remaining at higher values at least until day 14. The mRNA expressions of RGMa and neogenin were significantly suppressed in the damaged cortex until day 3. Interestingly, RGMa expression was suppressed most on day 1 and recovered over time. CONCLUSION: In the acute phase of TBI, gene expression of inflammatory cytokines significantly increased, and gene expressions of RGMa and neogenin significantly decreased in the inflammatory milieu of the damaged area. Despite the subsequent remission of inflammation, RGMa gene expression recovered to the normal level 1 week after TBI. Intrinsic regenerative response to acute brain injury might be hampered by the following recovery of RGMa expression, hinting at the possibility of functional RGMa inhibition as a new, effective maneuver against TBI.


Assuntos
Lesões Encefálicas Traumáticas , Proteínas Ligadas por GPI/metabolismo , Regeneração Nervosa/imunologia , Proteínas do Tecido Nervoso/metabolismo , Receptores CCR2/metabolismo , Fator de Necrose Tumoral alfa/metabolismo , Animais , Lesões Encefálicas Traumáticas/imunologia , Lesões Encefálicas Traumáticas/metabolismo , Modelos Animais de Doenças , Regulação da Expressão Gênica , Camundongos , Fatores de Tempo
8.
Drug Deliv ; 28(1): 542-549, 2021 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-33685317

RESUMO

We developed a biocompatible splenic vector for a DNA vaccine against melanoma. The splenic vector is a ternary complex composed of plasmid DNA (pDNA), biodegradable dendrigraft poly-L-lysine (DGL), and γ-polyglutamic acid (γ-PGA), the selective uptake of which by the spleen has already been demonstrated. The ternary complex containing pDNA encoding luciferase (pCMV-Luc) exhibited stronger luciferase activity for RAW264.7 mouse macrophage-like cells than naked pCMV-Luc. Although the ternary complex exhibited strong luciferase activity in the spleen after its tail vein injection, luciferase activity in the liver and spleen was significantly decreased by a pretreatment with clodronate liposomes, which depleted macrophages in the liver and spleen. These results indicate that the ternary complex is mainly transfected in macrophages and is a suitable formulation for DNA vaccination. We applied the ternary complex to a pUb-M melanoma DNA vaccine. The ternary complex containing pUb-M suppressed the growth of melanoma and lung metastasis by B16-F10 mouse melanoma cells. We also examined the acute and liver toxicities of the pUb-M ternary complex at an excess pDNA dose in mice. All mice survived the injection of the excess amount of the ternary complex. Liver toxicity was negligible in mice injected with the excess amount of the ternary complex. In conclusion, we herein confirmed that the ternary complex was mainly transfected into macrophages in the spleen after its tail vein injection. We also showed the prevention of melanoma metastasis by the DNA vaccine and the safety of the ternary complex.


Assuntos
Vacinas Anticâncer/administração & dosagem , Melanoma Experimental/terapia , Transgenes/genética , Vacinas de DNA/administração & dosagem , Animais , Vacinas Anticâncer/toxicidade , Ácido Clodrônico/administração & dosagem , Ácido Clodrônico/farmacologia , Injeções Intravenosas , Lipossomos , Fígado/metabolismo , Macrófagos/metabolismo , Masculino , Melanoma Experimental/genética , Camundongos , Camundongos Endogâmicos C57BL , Plasmídeos/genética , Ácido Poliglutâmico/análogos & derivados , Ácido Poliglutâmico/química , Polilisina/química , Células RAW 264.7 , Baço/metabolismo , Transfecção , Vacinas de DNA/toxicidade
9.
J Pharm Pharmacol ; 71(12): 1792-1799, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31579949

RESUMO

OBJECTIVES: This study aimed to investigate the effects of renal ischaemia/reperfusion (I/R)-induced acute kidney injury (AKI) on the distribution of midazolam (MDZ), a probe drug for cytochrome P450 3A (CYP3A) activity. METHODS: We established an AKI model inducing ischaemia of both renal pedicles for 60 min followed by 24-h reperfusion. MDZ was administered intravenously (i.v.) to the rats via the jugular vein, and then, blood samples were collected to determine the plasma concentration of MDZ. KEY FINDINGS: While the plasma concentration of MDZ after i.v. administration was decreased in the I/R rats, the tissue concentration was not altered. In addition, the tissue-to-plasma (T/P) ratio of MDZ was increased in the I/R rats. The unbound fraction of MDZ and the level of indoxyl sulphate (IS) in plasma were elevated in the I/R rats. Furthermore, the unbound fraction of MDZ was significantly increased by the addition of IS. CONCLUSIONS: These results indicated that the displacement of albumin-bound MDZ by IS changed the unbound fraction of MDZ and elevated the T/P ratio of MDZ in I/R rats.


Assuntos
Injúria Renal Aguda/fisiopatologia , Citocromo P-450 CYP3A/metabolismo , Midazolam/farmacocinética , Traumatismo por Reperfusão/fisiopatologia , Animais , Modelos Animais de Doenças , Masculino , Midazolam/administração & dosagem , Ligação Proteica , Ratos , Ratos Wistar , Albumina Sérica Humana/metabolismo , Distribuição Tecidual
10.
J Phys Chem Lett ; 9(8): 1833-1837, 2018 Apr 19.
Artigo em Inglês | MEDLINE | ID: mdl-29584951

RESUMO

We report here a kinetic study on the thermal equilibrium process between the biradical form and the quinoidal form starting from the singlet biradical form alone. A photochromic phenoxyl-imidazolyl radical complex repeatedly generates biradical species upon UV light irradiation, and the following thermal equilibrium process responsible for valence isomerization from the open-shell singlet biradical to the closed-shell quinoidal form is observed in the microsecond time region. The thermodynamic parameters for the equilibrium process were determined for the first time by nanosecond laser flash photolysis. We also found that visible-light excitation to the equilibrium state causes valence photoisomerization from the quinoidal to the biradical form, which returns thermally to the quinoidal form.

11.
J Trauma Acute Care Surg ; 84(4): 583-589, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29287057

RESUMO

BACKGROUND: Infection in patients with systemic inflammation is difficult to diagnose with a single biomarker. We aimed to clarify the time course of change in the gene expression profile of innate immune receptors in infectious or sterile inflammation and to establish an early diagnostic method using canonical discriminant analysis (CDA) of the gene expression profile. METHODS: To compare infectious and sterile inflammation, we used cecal ligation and puncture (CLP) and 20% full-thickness burn injury (Burn) models. C57BL/6 mice underwent sham treatment (n = 9 × three groups), CLP (n = 12 × three groups), or Burn (n = 12 × three groups) injury. Mice were killed at 6, 12, and 24 hours after injury, and total RNA was extracted from whole blood. We used quantitative real-time polymerase chain reaction to investigate gene expression of innate immune receptors Toll-like receptor 2 (TLR2), TLR4, TLR9, NLRP3 (nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3), and retinoic acid-inducible gene I. To evaluate all gene expression together as patterns, each value was standardized, and CDA was performed at each time point. RESULTS: Gene expression of TLR2 and TLR4 was already significantly increased in both CLP and Burn compared with sham mice at 6 hours after injury (p < 0.05). Gene expression of TLR9 was significantly decreased in CLP compared with sham and Burn mice at 12 hours and 24 hours after injury (p < 0.05) but not at 6 hours. Gene expression of NLRP3 was significantly increased in CLP and Burn compared with sham mice at 6 hours and 24 hours after injury (p < 0.05). In the CDA, each group showed distinctive gene expression patterns at only 6 hours after injury. Each group was clearly classified, and the classification error rates were 0% at all of the time points. CONCLUSIONS: Canonical discriminant analysis of the gene expression profile of innate immune receptors could be a novel approach for diagnosing the pathophysiology of complicated systemic inflammation from the early stage of injury.


Assuntos
Queimaduras/complicações , Diagnóstico Precoce , Regulação da Expressão Gênica , Imunidade Inata/genética , Inflamação/diagnóstico , RNA/genética , Receptores Imunológicos/genética , Animais , Queimaduras/imunologia , Citocinas/metabolismo , Modelos Animais de Doenças , Inflamação/etiologia , Inflamação/genética , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Reação em Cadeia da Polimerase em Tempo Real , Receptores Imunológicos/biossíntese , Reação em Cadeia da Polimerase Via Transcriptase Reversa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA